(Reuters) - The blood clot preventer Eliquis, sold by Pfizer Inc and Bristol-Myers Squibb Co, proved as effective as widely used warfarin in treating a dangerous condition known as venous thromboembolism and caused far less bleeding, according to data from a large clinical trial.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/new-clot-preventer-works-as-well-as.html
No comments:
Post a Comment